Flow cytometry was used to determine the Th9 cells (CD4+IL-9+T cells) proportion in the PBMCs of AITDs and NC group (Figures 3A–C), and the link between the proportion of Th9 cells and clinical indicators in the GD and HT groups was also investigated. This evidence concerns the gene CD4 and hematocrit.